VAMP2 chaperones α-synuclein in synaptic vesicle co-condensates.

TitleVAMP2 chaperones α-synuclein in synaptic vesicle co-condensates.
Publication TypeJournal Article
Year of Publication2024
AuthorsWang C, Zhang K, Cai B, Haller JE, Carnazza KE, Hu J, Zhao C, Tian Z, Hu X, Hall D, Qiang J, Hou S, Liu Z, Gu J, Zhang Y, Seroogy KB, Burré J, Fang Y, Liu C, Brunger AT, Li D, Diao J
JournalNat Cell Biol
Volume26
Issue8
Pagination1287-1295
Date Published2024 Aug
ISSN1476-4679
Keywordsalpha-Synuclein, Animals, Humans, Mice, Molecular Chaperones, Neurons, Parkinson Disease, Protein Binding, Rats, SNARE Proteins, Synaptic Vesicles, Vesicle-Associated Membrane Protein 2
Abstract

α-Synuclein (α-Syn) aggregation is closely associated with Parkinson's disease neuropathology. Physiologically, α-Syn promotes synaptic vesicle (SV) clustering and soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex assembly. However, the underlying structural and molecular mechanisms are uncertain and it is not known whether this function affects the pathological aggregation of α-Syn. Here we show that the juxtamembrane region of vesicle-associated membrane protein 2 (VAMP2)-a component of the SNARE complex that resides on SVs-directly interacts with the carboxy-terminal region of α-Syn through charged residues to regulate α-Syn's function in clustering SVs and promoting SNARE complex assembly by inducing a multi-component condensed phase of SVs, α-Syn and other components. Moreover, VAMP2 binding protects α-Syn against forming aggregation-prone oligomers and fibrils in these condensates. Our results suggest a molecular mechanism that maintains α-Syn's function and prevents its pathological amyloid aggregation, the failure of which may lead to Parkinson's disease.

DOI10.1038/s41556-024-01456-1
Alternate JournalNat Cell Biol
PubMed ID38951706
PubMed Central ID4255827
Grant ListR01NS121077 / / U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) /